Table 1.

Patient characteristics (n = 120)

Age, y
    Median (range)69.7 (41-87)
Primary therapy, n (%)
    Radical prostatectomy33 (28)
    Radiation therapy to the prostate35 (29)
    No primary treatment52 (43)
Prior systemic therapy, n (%)
    Androgen depletion120
    Received first-line chemotherapy32 (27)
    Receiving second-line regimens65 (54)
Sites of metastases disease, n (%)
    Soft tissue and no bone disease12 (10)
    Bone and soft tissue67 (56)
    Bone only41 (34)
Median (interquartile range)
Karnofsky performance status, %80 (80-90)
Hemoglobin, g/dL11.7 (10.3-12.6)
Albumin, g/dL4.1 (3.9-4.4)
Alkaline phosphatase, units/L107 (71-226.5)
PSA, ng/mL117 (40.9-399)